CK
ARIA

Carnick & Kubik’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Carnick & Kubik’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-7,000
Closed -$40.9K – 391
2015
Q3 		$40.9K Buy
+7,000
New +$53.9K 0.03% 214

Other funds holding ARIA

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Carnick & Kubik's ARIA Position: Q4 2015 in Review

Carnick & Kubik sold out of Ariad Pharmaceuticals Inc (ARIA) in Q4 2015, closing a stake of 7,000 shares — an estimated $40.9K sold.

Carnick & Kubik first reported a position in ARIA in Q3 2015 and held it in 1 quarter. The position peaked at $40.9K in Q3 2015. 172 funds tracked by Wall St. Rank hold ARIA as of Q4 2015.

  • Carnick & Kubik reported no remaining Ariad Pharmaceuticals Inc position as of Q4 2015 after selling out during the quarter.
  • Carnick & Kubik sold 7,000 Ariad Pharmaceuticals Inc shares in Q4 2015, an estimated $40.9K.
  • Carnick & Kubik first reported a position in Ariad Pharmaceuticals Inc in Q3 2015 and held it in 1 quarter.
  • Carnick & Kubik's Ariad Pharmaceuticals Inc position peaked at $40.9K in Q3 2015.
  • 172 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q4 2015.

Based on Carnick & Kubik's 13F filing for Q4 2015, filed 11 Feb 2016.